These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 8993095)

  • 1. Clinical and economic aspects of risperidone treatment in adults with mental retardation and behavioral disturbance.
    Lott RS; Kerrick JM; Cohen SA
    Psychopharmacol Bull; 1996; 32(4):721-9. PubMed ID: 8993095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of behavior disorders in mental retardation: report on transitioning to atypical antipsychotics, with an emphasis on risperidone.
    Aman MG; Gharabawi GM;
    J Clin Psychiatry; 2004 Sep; 65(9):1197-210. PubMed ID: 15367046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Risperidone in the treatment of psychotic disorders associated with mental retardation].
    Franco MA; Herraiz M; Martínez MJ; Fernández MC; Conde V
    Actas Esp Psiquiatr; 2000; 28(4):251-6. PubMed ID: 11116796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of risperidone among individuals with mental retardation: clinically supported or not?
    Singh AN; Matson JL; Cooper CL; Dixon D; Sturmey P
    Res Dev Disabil; 2005; 26(3):203-18. PubMed ID: 15668072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risperidone use in children with Down syndrome, severe intellectual disability, and comorbid autistic spectrum disorders: a naturalistic study.
    Capone GT; Goyal P; Grados M; Smith B; Kammann H
    J Dev Behav Pediatr; 2008 Apr; 29(2):106-16. PubMed ID: 18349709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacological treatment with risperidone in children with behavior disorders].
    Morant A; Mulas F; Hernández S; Roselló B
    Rev Neurol; 2001 Aug 1-15; 33(3):201-8. PubMed ID: 11588710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Risperidone in the treatment of psychotic, affective and behavioral symptoms associated to Alzheimer's disease].
    Barcia D; Giles E; Herraiz M; Moríñigo A; Roca M; Rodríguez A
    Actas Esp Psiquiatr; 1999; 27(3):185-90. PubMed ID: 10431061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-acting injectable risperidone: naturalistic study in three hospitals in Aquitaine].
    Raignoux C; Dusouchet T; Bret P; Queuille E; Biscay ML; Caron J; Bret MC
    Encephale; 2007 Dec; 33(6):973-81. PubMed ID: 18789790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of behavioral disorders in dementia with risperidone in psychogeriatric out-patients].
    Kurz A; Delius-Stute H; Rettig K; Schwalen S
    MMW Fortschr Med; 2003 Oct; 145 Suppl 3():89-95. PubMed ID: 15490773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risperidone for controlling aggressive behavior in a mentally retarded child: a case report.
    Maneeton N; Intaprasert S; Srisurapanont M
    J Med Assoc Thai; 2001 Jun; 84(6):893-6. PubMed ID: 11556472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic outcomes of antipsychotic agents in a Medicaid population: traditional agents vs. risperidone.
    Nightengale BS; Crumly JM; Liao J; Lawrence BJ; Jacobs EW
    Psychopharmacol Bull; 1998; 34(3):373-82. PubMed ID: 9803771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Risperidone in the ambulatory treatment of behavior disorders in demented patients of Alzheimer's type: a retrospective analysis].
    Sobów TM; Kłoszewska I
    Psychiatr Pol; 2001; 35(6):1033-45. PubMed ID: 11877883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Buspirone for autistic disorder in a woman with an intellectual disability.
    Brahm NC; Fast GA; Brown RC
    Ann Pharmacother; 2008 Jan; 42(1):131-7. PubMed ID: 18056831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of aggression with risperidone in children and adolescents with bipolar disorder: a case series.
    Saxena K; Chang K; Steiner H
    Bipolar Disord; 2006 Aug; 8(4):405-10. PubMed ID: 16879141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with risperidone in the treatment of behavioral and psychological symptoms of dementia.
    Onor ML; Saina M; Trevisiol M; Cristante T; Aguglia E
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):205-9. PubMed ID: 17020789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risperidone use at a state hospital: a clinical audit 2 years after the first wave of risperidone prescriptions.
    Chengappa KN; Sheth S; Brar JS; Parepally H; Marcus S; Gopalani A; Palmer A; Baker RW; Schooler NR
    J Clin Psychiatry; 1999 Jun; 60(6):373-8. PubMed ID: 10401915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risperidone: clinical outcome predictors and cost-effectiveness in a naturalistic setting.
    Finley PR; Sommer BR; Corbitt JL; Brunson GH; Lum BL
    Psychopharmacol Bull; 1998; 34(1):75-81. PubMed ID: 9564202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.
    Shea S; Turgay A; Carroll A; Schulz M; Orlik H; Smith I; Dunbar F
    Pediatrics; 2004 Nov; 114(5):e634-41. PubMed ID: 15492353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.